Receptor-Coupled Phosphoinositide Hydrolysis in Human Retinal Pigment Epithelium

Carbachol and histamine stimulated phosphoinositide (PPI) hydrolysis in cultured human retinal pigment epithelium (RPE), as reflected by an accumulation of 3 H-inositol phosphates in the presence of 10 m M Li + . Carbachol increased PPI hydrolysis to greater than 600% of basal with an EC 50 of 60 Μ M ; stimulation was linear up to 60 min. This activation likely occurred via the M 3 muscarinic cholinergic receptor based on the IC 50 values for 4-diphenylacetoxy- N -methylpiperidine methiodide (0.47 n M ), pirenzepine (280 n M ), and 11-[[2-[(diethylamino)methyl]-1-piperidinyl]-acetyl]-5,11-dihydro-6 H -pyrido[2,3- b ][1,4]benzodiazepin-6-one (1.4 Μ M ). Carbachol-mediated PPI hydrolysis was decreased by 80% in the absence of extracellular Ca 2+ . Histamine stimulated PPI turnover in a linear manner by 180% with an EC 50 of 20 Μ M by the H 1 histaminergic receptor. Serotonin, glutamate, norepinephrine, and dopamine were inactive. In human RPE, the resting cytoplasmic Ca 2+ concentration, as determined by fura-2 fluorescence, was 138 ± 24 n M . On the addition of carbachol, there was a 180% increase in peak intracellular Ca 2+ ; addition of histamine increased intracellular Ca 2+ by 187%. These results suggest receptor-mediated, inositol lipid hydrolysis is coupled to intracellular Ca 2+ flux in human RPE.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/66430/1/j.1471-4159.1991.tb03471.x.pd

Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient.

Clinical presentation of the immunoglobulin (Ig)-resistant DHTR episode in a adult patient with SC

An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid

No abstract is available for this article

Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma

Background: Lung cancer is a complex disease with many subtypes. However, histochemical characteristics, and genetic mutation determinations are contributing to better define therapeutic targets and new drugs. Although this guarantees patients the possibility of obtaining tailored treatment, it makes it more difficult for clinicians patient management more difficult for clinicians who have to define the most suitable therapeutic strategy and to deal with new treatment-related adverse events (TRAEs). It has been seen that the administration of a tyrosine kinase inhibitor (TKI) sequential to an immune checkpoint inhibitor (ICI) can lead to a higher rate of severe and life-threatening TRAEs. We report the case of a patient with advanced non-small cell lung cancer (NSCLC) who experienced severe hepatotoxicity and Stevens-Johnson syndrome (SJS) induced by osimertinib sequential to pembrolizumab. Case presentation: A 54-year-old woman with advanced NSCLC received one cycle of chemotherapy plus pembrolizumab after diagnosis. Ten days later she began osimertinib 80 mg daily because epidermal growth factor receptor (EGFR) analysis had revealed an exon 19 deletion. On day 23 of osimertinib the patient experienced an episode of grade (G) 3 hepatotoxicity resolved by discontinuing osimertinib and corticosteroid therapy. The patient restarted osimertinib 80 mg daily after the remission of symptoms but was hospitalized 14 days later following a second episode of severe G3 hepatotoxicity and the onset of SJS, successfully treated with high-dose corticosteroids. Despite the short exposure to osimertinib, the patient obtained a good pathological response. Conclusion: It is important to alert clinicians to carefully evaluate the sequential therapeutic strategy in patients with NSCLC who are candidates for TKI- or ICI-based treatment. Our experience suggests that the use of tyrosine kinase inhibitors (TKIs) as front-line treatment is a more reasonable and safe option for EGFR-mutated lung adenocarcinoma, with ICIs considered as a possible further treatment in sequential approaches

Synthesis and crystal structure of C2/c Ca(Co, Mg)Si2O6 pyroxenes : effect of the cationic substitution on the cell volume

A series of clinopyroxenes along the CaMgSi2O6-CaCoSi2O6 join was synthesized by quenching from melt at 1500\ub0C and subsequent annealing at 1250\ub0C (at 0.0001 GPa). This protocol proved to be the most effective to obtain homogenous, impurity free and stoichiometric pyroxenes as run products. Electron microprobe analyses in energy-dispersive mode were conducted and single-crystal X-ray diffraction data were collected on the Ca(CoxMg1-x)Si2O6 pyroxenes, with x = 0.2, 0.4, 0.5, 0.6; anisotropic structure refinements were performed. The effects of the cation substitution at the M1 site are described at the atomic level. The experimental findings of this study allowed us to extend the comparative analysis of the structural features of pyroxenes with divalent cations at the M1 and M2 sites

New generation anaplastic lymphoma kinase inhibitors

Anaplastic lymphoma kinase (ALK) gene translocations are pro-tumoral driver alterations that encompass 3*7% of non-squamous non-small cell lung cancer (NSCLC) with specific, clinic and histologic features. The therapeutic strategy depends on anti-ALK tyrosine kinase inhibitors (TKIs) of which crizotinib was the first approved for clinical use. Despite its use improved significantly progression-free survival, overall response rate and duration of response of this illness, after a median period of 10.9 months all patients progress due to the development of acquired resistance mutations in the ALK tyrosine kinase domain in approximately one third of patients. Moreover, 60-90% of patients treated with crizotinib has a progression in the central nervous system (CNS) in absence of extracranial worsening of the disease. This is primarily attributed to poor CNS penetration by crizotinib as many pre-clinical and clinical models suggest. For instance, in order to overtake acquired resistance to crizotinib, prolong the control of the disease and manage CNS localizations, several II and III generation TKIs have been developed. Some of them were approved after the failure of crizotinib (ceritinib, alectinib, brigatinib and lorlatinib) and in first line setting (ceritinib, alectinib and brigatinib) while others are still under evaluation for TKI-naive patients such as lorlatinib, ensartinib and entrectinib. In this review we will discuss the most recent results of new TKIs in order to describe a fast growing therapeutic landscape in this setting

Bionics-based surgical training using 3D printed photopolymers and smart devices

Additive manufacturing technologies support the realization of surgical training devices using, typically, photopolymers-based materials. Unfortunately, the material jetting family, able to print a large range of soft and hard polymers, requires expensive machines and materials, which are not always available. On the other hand, vat polymerization fails in the resolution/volume ratio and in the mechanical properties reconstruction. Stereolithographic 3D printers, mostly used in dental surgery, make possible to realize cheap and sustainable models for training activity using only one material, reducing the possibility to obtain different mechanical characteristics. Moreover, the printed objects have to be treated (i.e. curing post-processing) in order to obtain the required performances, that could be preserved for long term storing. The aim of the proposed approach is to assure the surgeons' skills improvement through bionic-based surgical 3D printed models and smart devices, able to reproduce the same perception of a real surgical activity. We demonstrated how it is possible develop smart devices capable to take into account the same characteristics of different materials (i.e. bone and spongy bone) even if stored for a long time

Bionic for training: Smart framework design for multisensor mechatronic platform validation

Home monitoring supports the continuous improvement of the therapy by sharing data with healthcare professionals. It is required when life-threatening events can still occur after hospital discharge such as neonatal apnea. However, multiple sources of external noise could affect data quality and/or increase the misdetection rate. In this study, we developed a mechatronic platform for sensor characterizations and a framework to manage data in the context of neonatal apnea. The platform can simulate the movement of the abdomen in different plausible newborn positions by merging data acquired simultaneously from three-axis accelerometers and infrared sensors. We simulated nine apnea conditions combining three different linear displacements and body postures in the presence of self-generated external noise, showing how it is possible to reduce errors near to zero in phenomena detection. Finally, the development of a smart 8Ws-based software and a customizable mobile application were proposed to facilitate data management and interpretation, classifying the alerts to guarantee the correct information sharing without specialized skills

Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

Background: Despite sensitivity to first-line chemotherapy, most small-cell lung cancer (SCLC) patients relapse. In this setting, topotecan demonstrated modest activity with significant toxicity. Paclitaxel was also active. This study was designed to evaluate activity and safety of nab-paclitaxel in relapsed SCLC. Methods: In this multicentre prospective Phase 2 trial, patients with refractory or sensitive SCLC progressed to first-line platinum-based chemotherapy received nab-paclitaxel 100 mg/smq on days 1, 8, 15 every 4 weeks up to six cycles, progressive disease or intolerable toxicity. Primary endpoint was investigator-assessed objective tumour response. Secondary endpoints were toxicity, progression-free survival (PFS) and overall survival (OS). Results: Of the 68 patients treated, partial response was 8% in the refractory cohort and 14% in the sensitive cohort. Most common toxicities of any grade were fatigue (54%), anaemia (38%), neutropenia (29%), leukopenia (26%) and diarrhoea (21%). Median PFS was similar in both refractory (1.8 months) and sensitive cohorts (1.9 months), while median OS was longer in sensitive one (6.6 versus 3.6 months). Conclusions: Although nab-paclitaxel has shown some modest anti-tumour activity in relapsed SCLC, associated with a favourable toxicity profile, the primary end-point of the study was not met. Clinical Trial registration: Clinical Trial registration number is ClinicalTrials.gov Identifier: NCT03219762

Recursion and Ambiguity: a Linguistic and Computational Perspective

In this chapter I will be concerned with what characterizes human language and the parser that computes it in real communicative situations. I will start by discussing and dismissing Hauser, Chomsky and Fitch's(2002) (HC&F) disputed claim that the "only uniquely human component of the faculty of language" be "recursion". I will substantiate my rejection of HC&F's claims, with the fact that recursion only appears in mature and literate language - an opinion also shared by some papers in a book on recursion by Harry van der Hulst (2010). I will then present in detail Chomsky's proposal - now part of the Minimalist Theory (MT) - of the architecture of the human parser as being based on Phases. I will accept this part of the theory and compare it with the computational architecture contained in a system for deep text understanding called Getaruns (Delmonte,2007;2009). I will then argue in favour of what I regard the peculiar component of human language faculty that is "the ability to associate meaning to deficient propositions and generic linguistic expressions, which are highly ambiguous in their structure”. And this is also due to the presence of recursion (but not only). I will then speak in favour of a parser that takes "context" into account and strives for a "complete" syntactic representation. As to the problem of ambiguity, I will introduce the use of a computational device, a lookahead mechanism, which is presented in association with the need to specify UG parameters characterizing a given language. I will discuss the use of psychologically viable Parsing Strategies implemented in the parser to overcome ambiguity and prevent Garden Path, whenever possible. This will be highlighted by reference to peculiar features associated to different languages, Italian and English. Eventually, I will present a theory that encompasses all my previous proposals and is called LSLT